Advances in Immunology, Vol 122

  • ID: 2735742
  • Book
  • 310 Pages
  • Elsevier Science and Technology
1 of 4
Advances in Immunology, a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, including molecular and cellular activation mechanisms, phylogeny and molecular evolution, and clinical modalities. Edited and authored by the foremost scientists in the field, each volume provides up-to-date information and directions for the future.

- Contributions from leading authorities- Informs and updates on all the latest developments in the field

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Note: Product cover images may vary from those shown
2 of 4
  1. Regulation of Immunoglobulin Class Switch Recombination: Choreography of Non-Coding Transcription, Targeted DNA Deamination and Long-Range DNA Repair
    Allysia Matthews, Simin Zheng, Lauren DiMenna and Jayanta Chaudhuri
  2. Two Forms of Adaptive Immunity in Vertebrates: Similarities and Differences
    Masanori Kasahara and Yoichi Sutoh
  3. Recognition of Tumors by the Innate Immune System and Natural Killer Cells
    Assaf Marcus, Benjamin G. Gowen, Thornton W. Thompson, Alexandre Iannello, Michele Ardolino, Weiwen Deng, Lin Wang, Nataliya Shifrin and David H. Raulet
  4. Signaling Circuits in Early B Cell Development
    Michael Reth and Peter Nielsen
  5. Interleukin 10 Receptor Signaling: Master Regulator of Intestinal Mucosal Homeostasis in Mice and Humans
    Dror S. Shouval, Jodie Ouahed, Amlan Biswas, Jeremy A. Goettel, Bruce Horwitz, Alexio M. Muise and Scott B. Snapper
  6. Development of Mast Cells and Importance of their Tryptase and Chymase Serine Proteases in Inflammation and Wound Healing
    Jeffrey Douaiher, Julien Succar, Luca Lancerotto, Michael F. Gurish, Dennis P. Orgill, Matthew J. Hamilton, Steven A. Krilis and Richard L. Stevens
  7. Why does Somatic Hypermutation by AID Require Transcription of its Target Genes?
    Ursula Storb
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Alt, Frederick W.
Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown